Latest database descriptions

Describe the persistence of secondary prevention therapeutics, between 3 and 18 months after hospitalization for a first acute coronary syndrome (ACS), in patients monitored by private or hospital cardiologists

Describe the persistence of secondary prevention therapeutics, between 3 and 30 months after hospitalization for a first acute coronary syndrome (ACS), in patients monitored by general practitioners

Determine the proportion of patients on lipid-lowering drugs who reach the LDL-C goals recommended in guidelines.

This study aims to improve knowledge regarding in vitro fertilisation and to better understand the relationship between the number of implanted embryos/blastocyst transfers and birth.